AbbVie News Center - News (2024)

AbbVie on Twitter

Looking for more news from AbbVie? Follow us onsocial media.

Month Year

Month Year

See Also

Best Pharma Stocks in India to Invest in 2024 - Angel One AbbVie (ABBV) Stock Forecast, Price Targets and Analysts Predictions - TipRanks.com AbbVie Stock: To Buy Or Not To Buy (NYSE:ABBV)Abbvie Stock Forecast: up to 177.541 USD! - ABBV Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis

Get News Alerts by Email

January 09, 2024
AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European Union
January 08, 2024
Lutikizumab Showed Positive Results in a Phase 2 Trial of Adults with Moderate to Severe Hidradenitis Suppurativa as Program Advances to Phase 3
January 04, 2024
AbbVie and Umoja Biopharma Announce Strategic Collaboration to Develop Novel In-Situ CAR-T Cell Therapies
January 04, 2024
AbbVie to Host Full-Year and Fourth-Quarter 2023 Earnings Conference Call
See Also
7 Dividend Stocks That Will Pay You Through Any Market Turmoil
January 02, 2024
AbbVie to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 09, 2023
New Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Shows Strong, Durable Treatment Response for Patients with Difficult-To-Treat Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
December 06, 2023
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
December 05, 2023
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
November 30, 2023
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
November 29, 2023
AbbVie Announces Positive Topline Results from Phase 2 LUMINOSITY Trial Evaluating Telisotuzumab-Vedotin (Teliso-V) for Patients with Previously Treated Non-Small Cell Lung Cancer (NSCLC)

Show 5 10 25 50 100 per page

AbbVie News Center - News (2024)

Top Articles

7 Places To Save Your Extra Money | Bankrate

A Trillion-Dollar Dividend Growth Stock to Buy and Hold Forever | The Motley Fool

WATCH— Reagan 2024 FullMovie Free Online ON 123MOVIES

Fifty Shades Freed | Rotten Tomatoes

J&R Cycle Villa Park

Death By Bread Evansville Indiana

How to get your Family Dollar Paystub: Doculivery Portal

How to Access Your Doculivery Pay Stubs Effortlessly?

Ridge Culver Wegmans Pharmacy

VA benefits for service members | Veterans Affairs

Stubhub Hozier Tickets

Iose Epenesa Espn

Latest Posts

You Trade ECSA Review 2024 - Get refund if scammed by broker

Why The British "Stiff Upper Lip" Might Be Costing You Money • Homely Economics

Article information

Author: Jerrold Considine

Last Updated: 2024-07-07T05:30:54+07:00

Views: 6035

Rating: 4.8 / 5 (58 voted)

Reviews: 89% of readers found this page helpful

Author information

Name: Jerrold Considine

Birthday: 1993-11-03

Address: Suite 447 3463 Marybelle Circles, New Marlin, AL 20765

Phone: +5816749283868

Job: Sales Executive

Hobby: Air sports, Sand art, Electronics, LARPing, Baseball, Book restoration, Puzzles

Introduction: My name is Jerrold Considine, I am a combative, cheerful, encouraging, happy, enthusiastic, funny, kind person who loves writing and wants to share my knowledge and understanding with you.